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        Our previous research demonstrated that the 
saliva of   Anopheles stephensi   induces a rapid de-
granulation of cutaneous mast cells (MCs) in mice, 
followed by an infl  ux of neutrophils at the bite 
site and lymph node hyperplasia (  1  ). Moreover, 
this mosquito saliva  –  induced infl  ammatory re-
sponse leads to a down-regulation of subsequent 
T cell  –  mediated immune responses, as assessed 
by a model of the delayed hypersensitivity reac-
tion. This down-regulation of antigen-specifi  c 
T cell responses is MC dependent (  2  ). These 
results led us to hypothesize that infl  ammatory 
responses infl  uence the course of infection with 
  Plasmodium   parasites. 
  Some reports indicate that specifi  c compo-
nents of the innate immune system, including 
eosinophils (  3  ), basophils (  4  ), and MCs (  5  ), could 
play important roles in the pathogenesis of ma-
laria. Increased levels of histamine in plasma and 
tissue, derived from basophils and MCs, are as-
sociated with the severity of disease in humans 
infected with   P. falciparum   and in several animal 
models of infection with   Plasmodium   (  6  –  8  ). 
In addition, higher levels of IgE, which binds 
to basophils and MCs and can trigger histamine 
release, are associated with the severity of in-
fection with   P. falciparum   (  9  ). 
  The eff  ects of histamine are exerted through 
three classical G protein  –  coupled histamine re-
ceptor subtypes termed H1R, H2R, and H3R, 
which are thoroughly described pharmacologi-
cally (  10  ), and a recently identifi  ed fourth mem-
ber of the histamine receptor family, H4R (  11  ). 
H1R mediates most of the proinfl  ammatory 
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  From the inoculation of   Plasmodium   sporozoites via   Anopheles   mosquito bites to the 
development of blood-stage parasites, a hallmark of the host response is an infl  ammatory 
reaction characterized by elevated histamine levels in the serum and tissues. Given the 
proinfl  ammatory and immunosuppressive activities associated with histamine, we postu-
lated that this vasoactive amine participates in malaria pathogenesis. Combined genetic 
and pharmacologic approaches demonstrated that histamine binding to H1R and H2R 
but not H3R and H4R increases the susceptibility of mice to infection with   Plasmodium  . 
To further understand the role of histamine in malaria pathogenesis, we used histidine de-
carboxylase  –  defi  cient (HDC      /     ) mice, which are free of histamine. HDC      /      mice were highly 
resistant to severe malaria whether infected by mosquito bites or via injection of infected 
erythrocytes. HDC      /      mice displayed resistance to two lethal strains:   Plasmodium berghei   
(  Pb  ) ANKA, which triggers cerebral malaria (CM), and   Pb   NK65, which causes death with-
out neurological symptoms. The resistance of HDC      /      mice to CM was associated with 
preserved blood  –  brain barrier integrity, the absence of infected erythrocyte aggregation in 
the brain vessels, and a lack of sequestration of CD4 and CD8 T cells. We demonstrate that 
histamine-mediated signaling contributes to malaria pathogenesis. Understanding the basis 
for these biological effects of histamine during infection may lead to novel therapeutic 
strategies to alleviate the severity of malaria. 396 HISTAMINE-MEDIATED SIGNALING IS DETRIMENTAL DURING MALARIA INFECTION | Beghdadi et al.
In vascular endothelial cells, H1R stimulation leads to several 
cellular responses, including the release of nitric oxide (  19  ), 
and enhancements in vascular permeability, particularly in post-
capillary venules as a result of endothelial cell contraction (  20, 21  ). 
Several of these eff  ects of histamine might be exploited by 
  Plasmodium   to survive in its mammalian host. The increase in 
vascular permeability appears to be a component of malaria 
pathogenesis and could be advantageous for the parasites, as 
sporozoites or blood-stage parasites, because it facilitates their 
entry and exit from blood vessels. The vasodilatory eff  ects of 
histamine might promote the spread of the parasite through 
the vasculature, and histamine can increase endothelial ex-
pression of thrombomodulin, which is both an anticoagulant 
and a receptor for parasitized erythrocyte sequestration. 
Finally, the putative benefi  t of histamine signaling to   Plasmo-
dium   is strongly supported by the existence of a parasite-derived 
homologue of the mammalian histamine-releasing factor 
known as translationally controlled tumor protein (TCTP). 
  The aim of this work was to directly assess the rele-
vance of histamine in malaria pathogenesis and its association 
with disease severity. Using mice genetically defi  cient in H1R 
(H1R      /     ), H2R (H2R      /     ), and histidine decarboxylase 
(HDC      /     ), as well as targeting the four histamine receptors 
(H1R, H2R, H3R, and H4R) by antihistamine drugs, we dem-
onstrate a deleterious eff  ect of histamine-associated  infl  ammatory 
eff  ects of histamine (  12  ). The antiinfl  ammatory and immuno-
suppressive eff  ects of histamine, such as inhibition of poly-
morphonuclear chemotaxis ( 13  ), IL-12 secretion by monocytes, 
and induction of IL-10 production (  14  ), are largely depen-
dent on stimulation of H2R, which is coupled to the adeny-
lyl cyclase pathway. IL-10, on the other hand, is a suppressor 
cytokine and a major regulatory agent of infl  ammatory re-
sponses (  15  ). H3R elicits an increase in intracellular calcium 
concentration and regulates cytokine release in alveolar mac-
rophages and MCs (  16  ). Histamine enhances intracellular Ca  2+   
concentration and actin polymerization in immature DCs via 
activation of H1R and H3R, which also enhances chemo-
taxis of these cells. In maturing DCs, histamine promotes an 
increase of cAMP and IL-10 production, whereas IL-12 se-
cretion is inhibited (  17  ). These histamine-mediated eff  ects on 
cAMP and IL-10, as well as inhibition of IL-12 secretion, are 
mainly mediated by H2R and H3R. In addition, histamine 
inhibits the capacity of mature DCs to induce allogeneic Th1 
responses, suggesting that histamine might infl  uence the polari -
zation of Th cell development (  17  ) . 
  Histamine also modulates several biological functions of 
vascular endothelial cells. During an acute infl  ammatory re-
sponse, the histamine-induced increase of P-selectin (CD62P) 
expression on endothelial cells mediates the initial capture of 
infl  ammatory cells, including neutrophils, from the blood (  18  ). 
    Figure 1.         Role of H1R and H2R in   Pb   infection.   Histamineamia was measured by ELISA in naive and infected C57BL/6 mice at different time points 
after inoculation of   Pb   NK65 (A) or   Pb   ANKA (B) through mosquito bites. Values represent the mean   ±   SD. ***, P = 0.003 (A); * and ***, P   <   0.04 and 0.004 (B), 
respectively, versus plasma histamine levels in uninfected mice. (C) The determination of histamine levels was performed in the brains from naive and 
infected C57BL/6 mice 7 d after the inoculation of   Pb   ANKA through mosquito bites. Data represent the mean   ±   SD. **, P   <   0.003. Wild-type C57BL/6 mice 
(squares) or H1R     /     (diamonds) and H2R     /     (triangles) mice were infected either with infectious mosquito bites (seven to nine per mouse; D and E) or 
with 10  6   infected erythrocytes per mouse (F and G). Survival and parasitemia were recorded. Signifi  cant differences were observed between C57BL/6 and 
H1R     /     and H2R     /     mice after infection by mosquito bites (  n   = 7; P   <   0.042 and 0.035, respectively; D), and after infection with erythrocytes (  n   =  7; 
P   <   0.008 and 0.007, respectively; F). Differences in parasitemia between groups were not signifi  cant. Each group consisted of seven mice. Data shown 
are from three independent experiments.     JEM VOL. 205, February 18, 2008 
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three groups (  Fig. 1 E  ). To determine whether the relative 
resistance of H1R      /      and H2R      /      mice was confi  ned to the 
preerythrocytic stage of infection, mice were also inoculated 
with infected erythrocytes, and mortality and parasitemia 
were monitored. Although mice from all groups infected in 
this manner died earlier than when infected through mosquito 
bites, a similar pattern of divergence between wild-type C57BL/6 
mice and H1R      /      and H2R      /      mice was observed (  Fig. 1, 
F and G  ). These data indicate that regardless of the develop-
mental stage of the parasites used for infection, histamine in-
teraction with either H1R or H2R hasten the fatal outcome, 
thus suggesting that the detrimental eff  ects of histamine on the 
course of disease operate during the late stage of infection. 
  These fi  ndings were confi  rmed using a pharmacological 
intervention consisting of repeated administration of four his-
tamine inhibitors  —  levocetirizine (H1R inhibitor), cimetidine 
(H2R inhibitor), imetit (H3R inhibitor), and JNJ 7777120 
(H4R inhibitor)  —  before infection with 5   ×   10  5   blood-stage 
parasites (  Pb   NK65). Mice treated with either levocetirizine or 
cimetidine died signifi  cantly later than similarly infected but 
untreated mice ( Fig. 2 A ).   In contrast, imetit and JNJ 7777120 
had no eff  ect on mice survival as compared with untreated 
mice. Again, there was no diff  erence in the parasitemia between 
antihistamine-treated or untreated mice when infected with 
blood-stage parasites (  Fig. 2 B  ). 
  Susceptibility to infection with   Pb   is associated
with the   HDC   gene 
  Because histamine is known to act through four receptors 
(H1R, H2R, H3R, and H4R), obstructing signaling of only 
a single histamine receptor still permits manifestations of the 
histamine eff  ects by the other receptors. Therefore, to deter-
mine the eff  ect of histamine on the course of disease induced 
by   Plasmodium   in a comprehensive manner, we used mice 
defi  cient in HDC, the enzyme that converts histidine into 
histamine. As a result of this mutation introduced into the 
responses in malaria infection. Therefore, suppressing the bio-
logical eff  ects of histamine may prove to be a new strategy to 
reduce the severity of diseases resulting from infections with 
  Plasmodium   parasites. 
    RESULTS   
  H1R- and H2R-mediated signaling play a role in the 
pathogenesis of infection with   Plasmodium berghei   (  Pb  ) 
  In a preliminary attempt to appraise the impact of histamine 
on the course of infection with   Plasmodium  , we compared 
histamine levels in the plasma of mice infected or not with   Pb  . 
As shown in   Fig. 1  , the levels of histamine in plasma increased 
signifi  cantly over time in C57BL/6 mice inoculated with   Pb   
NK65 and   Pb   ANKA by mosquito bites.   It can be observed 
that although histamine levels increased relatively late at day 
15 (P = 0.045) and became signifi  cantly high only at the on-
set of disease (day 20; P = 0.003; see   Fig. 2 A  ) after infection 
with   Pb   NK65, the rise in histaminemia occurred much ear-
lier and became signifi  cantly higher at day 5 after infection 
(P   <   0.04) and constantly increased up to the time of death of 
most of the mice (day 8; P   <   0.004; see   Fig. 3 C  ) after infec-
tion with   Pb   ANKA. A similar increase in histamine levels 
has been reported in humans infected with   P. falciparum   (  22  ). 
We also determined the levels of histamine in the brains of 
infected mice after infection with   Pb   ANKA, which causes 
cerebral malaria (CM), and found signifi  cantly higher amounts 
of histamine as compared with control mice (  Fig. 1 C  ). To 
assess whether histamine signaling plays a role in the patho-
genesis of malaria, we fi  rst determined the mortality and para-
sitemia of mice genetically defi  cient for H1R or H2R infected 
with parasites from a lethal strain of   Pb   NK65 via   An. stephensi   
mosquito bites. Results illustrate that, compared with wild-
type C57BL/6 mice, H1R      /      and H2R      /      mice displayed 
a delayed mortality; specifi  cally, death was delayed by 3 d in 
histamine receptor  –  defi  cient mice (  Fig. 1 D  ). Interestingly, 
comparable parasitemia was observed between mice from the 
    Figure 2.         Prolonged survival after treatment with antihistamine drugs.   Wild-type C57BL/6 mice were left untreated (squares) or treated (triangles) 
with the histamine inhibitors levocetirizine, cimetidine, imetit, and JNJ7777123 (for H1R, H2R, H3R, and H4R, respectively) before and during infection 
with 10  6   infected erythrocytes per mouse. Survival (A) and parasitemia (B) were monitored over time. These data are from three independent experiments. 
No signifi  cant difference was observed for parasitemia between groups (7  –  15 mice per group). Data are shown as means   ±   SD.     398 HISTAMINE-MEDIATED SIGNALING IS DETRIMENTAL DURING MALARIA INFECTION | Beghdadi et al.
signs before dying within 8 d (median survival = day 7;   Fig. 4  ).   
In contrast, HDC      /      mice did not exhibit signs of CM, and 
death occurred on average at day 20, which was consistent 
with hyperparasitemia-induced anemia (  Fig. 4  ). These data 
indicate that the resistance of HDC      /      mice to CM does not 
depend on the stage of parasite development used for infection. 
These data also suggest that histamine signaling mediates its 
detrimental eff  ect later in infection, but they do not exclude 
the possibility that histamine signaling also plays a role at the 
preerythrocytic stage. 
HDC gene, mice cannot produce histamine. HDC      /      mice 
were infected with   Pb   NK65 via mosquito bites, and mortal-
ity and parasitemia were monitored over time. Strikingly, no 
mortality was observed in HDC      /      mice during the period 
of observation (  >  35 d) as compared with wild-type C57BL/6 
mice, which died within 25 d after infection (  Fig. 3 A  ).   In 
contrast to C57BL/6 mice, which developed high levels of 
blood-stage parasites (mean = 12% of RBCs), only 30% of 
HDC      /      mice developed a blood-stage infection with only 
low levels of parasitemia (  <  2% of RBCs) and, ultimately, 
cleared the parasites (  Fig. 3 B  ). 
  To examine whether the resistance to disease demon-
strated by HDC      /      mice was restricted to one strain of   Pb   
and whether histamine signaling aff  ected progression to CM, 
mice were infected via mosquito bites with   Pb   ANKA para-
sites, which cause CM, and their survival and parasitemia were 
monitored. As expected, C57BL/6 mice infected with   Pb   
ANKA died from CM within 10 d (  Fig. 3 C  ). All C57BL/6 
mice displayed neurological signs within 9  –  11 d (  23  ), and 
death occurred within the next 24 h (median survival = day 10). 
In sharp contrast, HDC      /      mice did not develop CM and 
died later (median survival = day 24) of parasitemia-induced 
anemia (  Fig. 3 D  ) without neurological signs (  Fig. 3 C  ). These 
data strongly suggest that histamine is involved in the patho-
genesis of CM, confi  rming and extending the connection be-
tween histamine signaling and malaria disease severity. 
  The resistance of HDC      /      mice to CM induced by the 
inoculation of parasites via mosquito bites prompted us to 
explore at what stage of parasite development histamine me-
diated this eff  ect; thus, we assessed whether these mice were 
similarly resistant to infection with blood-stage parasites. 
After infection with 10  6   infected erythrocytes, C57BL/6 mice 
were susceptible to CM, displaying characteristic neurological 
    Figure 3.         HDC       /       mice are resistant to lethal infection by two     Pb   strains of parasites.   Mortality (A and C) and parasitemia (B and D) were re-
corded for wild-type C57BL/6 mice (squares) or HDC     /     mice (diamonds) infected via mosquito bites with   Pb   NK65 (A and B) or with   Pb   ANKA (C and D). 
Groups consisted of 10 mice. Differences in parasitemia are signifi  cant at each time point from day 12 until day 19 (P   <   0.001) in B but not in D, and data 
are shown as means   ±   SD. Three independent experiments were performed with similar results.     
    Figure 4.         HDC       /       mice are resistant to lethal infection by blood-
stage parasites.     Survival rates (A) and parasitemia (B) were compared 
between wild-type C57BL/6 mice (squares) and HDC     /     mice  (diamonds) 
that received 10  6    Pb   ANKA  –  infected erythrocytes i.p. per mouse. *, P   <   0.02 
for parasitemia. The cumulative results of four independent experiments 
(10 mice per group) are shown. Data are shown as means   ±   SD.     JEM VOL. 205, February 18, 2008 
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did not show signifi  cant extravasation of the dye in the cere-
bral cortex, similar to uninfected C57BL/6 and HDC      /      con-
trol mice. Thus, infected C57BL/6 mice have a disruption of 
the BBB integrity concomitant with the appearance of neu-
rological signs, whereas similarly infected HDC      /      mice do 
not exhibit detectable alteration of their BBB integrity. 
  The neurological signs that characterize CM are generally 
accompanied by the sequestration of infected erythrocytes in 
the cerebral vasculature. Histological analysis of brain sections 
obtained from naive or infected C57BL/6 mice revealed large 
erythrocyte aggregates observed in sections from olfactory bulbs 
and other anatomical parts of the brain (  Fig. 5 B  , panels 1 and 2). 
In sharp contrast, such aggregates were not detected in sam-
ples from infected HDC      /      mice (  Fig. 5 B  , panels 5 and 6). 
  Role of the blood  –  brain barrier (BBB) during CM 
  A central feature of CM pathology after infection with   Pb   
ANKA is the alteration of the BBB (  24  ). Increased BBB per-
meability may be mediated through the action of vasoactive 
amines, such as histamine (  25  ), released from perivascular 
brain MCs (  26, 27  ). To assess the status of the BBB during 
infection in our model system, C57BL/6 and HDC      /      mice 
were infected with 10  6     Pb   ANKA  –  parasitized erythrocytes, 
and the BBB integrity was determined by an Evans blue dye 
exclusion assay. At day 7, when C57BL/6 mice develop neu-
rological signs, the BBB permeability was evaluated by visu-
alization of the dye extravasation in the brain, as refl  ected by 
the appearance of a blue color in the cerebral cortex (  Fig. 5 A  ).   
In contrast to infected C57BL6 mice, infected HDC      /      mice 
    Figure 5.         Preserved BBB and a lack of sequestration of infected erythrocytes in the brain of HDC       /       mice.   (A) Wild-type C57BL/6 mice and 
HDC     /     mice were inoculated i.p. with 10  6   infected erythrocytes of   Pb   ANKA per mouse. At day 7 after infection, mice were injected with a solution of 
Evans blue dye and were perfused with PBS 1 h later, and macroscopic observation was made of the brains. Brains from uninfected mice were used as 
controls. (B) Sections from the brains of the same mice were stained with MGG. Blood-stage parasites associated with sequestered erythrocytes (panels 
1 and 2) in the brain could be visualized by fl  uorescence because of their expression of GFP (white, arrows; panel 2). No fl  uorescence could be observed in 
brain sections from uninfected and infected HDC     /     mice (panels 5 and 6). Data shown are representative of six mice per group. (C) The density of erythro-
cyte aggregates in brain sections of infected and control HDC     /     and C57BL/6 mice were expressed as the mean of aggregates per fi  eld and counted in 
50 consecutive microscopic fi  elds. These data are from two different experiments. *, P   <   0.05 between infected HDC     /     and C57BL/6 mice. Data are 
shown as means   ±   SD. Bar, 100    m.   400 HISTAMINE-MEDIATED SIGNALING IS DETRIMENTAL DURING MALARIA INFECTION | Beghdadi et al.
number of CD8  +   T cells sequestered in the brain, whereas 
HDC      /      mice show only a 1.3-fold increase (  Fig. 6  ).   Re-
garding the CD4  +   T cell sequestration, infected C57BL/6 
mice displayed a 2.7-fold increase, whereas HDC      /      mice 
had only a 1.18-fold increase. 
  Vascular cell adhesion molecule 1 (  VCAM-1; CD106)   
and intercellular adhesion molecule 1 (  ICAM-1; CD54)   ex-
pression by capillary endothelial cells in the brain tissue medi-
ates the fi  rm and irreversible adhesion of leukocytes through 
very late antigen 4 (CD49d), lymphocyte function-associated 
antigen 1 (CD11a/CD18), and Mac-1 (CD11b/CD18), re-
spectively (  30, 31  ). Because ICAM-1 was found in many 
studies to be associated with CM, we focused our analysis on the 
expression of this adhesion molecule. We found that ICAM-1 
protein was signifi  cantly increased in the brain microvessels 
of CM-susceptible C57BL/6 mice compared with those of 
CM-resistant HDC      /      mice (  Fig. 7 A  ).   To quantify these 
histological changes, the number of cerebral vessels express-
ing ICAM-1 was determined by immunohistochemistry. 
Notably, these aggregates consisted mainly of infected erythro-
cytes, as shown by fl  uorescence measurable because GFP-
expressing parasites were used for infection (  Fig. 5 B  , panel 2). 
Quantifi  cation of brain lesions, expressed as the number of 
erythrocyte aggregates in 50 consecutive microscopic fi  elds, 
confi  rmed a signifi  cantly larger number of infected erythro-
cyte aggregates observed in C57BL/6 mice as compared with 
HDC      /      mice (  Fig. 5 C  ). These data show that the mainte-
nance of the BBB integrity in infected HDC      /      mice is asso-
ciated with a lack of infected erythrocyte sequestration in brain 
capillaries and an absence of CM. 
  The resistance of HDC       /       mice to the development of CM 
after infection with   Pb   ANKA correlates with a drastic 
reduction of brain-infi  ltrating T cells and decreased 
expression of adhesion molecules 
  During infection with   Pb   ANKA, the development of CM is 
strongly associated with the recruitment and activation of 
T cells in the brain ( 28, 29 ). Accordingly, we examined whether 
such T cell recruitment occurred in HDC      /      mice. Brain-
infiltrating leukocytes were isolated from C57BL/6 or 
HDC      /      mice 7 d after infection with   Pb   ANKA, and the 
percentage and absolute numbers of CD4  +   and CD8  +   T cells 
were determined. Compared with uninfected control mice, 
infected C57BL/6 mice displayed a 3.6-fold increase in the 
    Figure 6.         Absence of sequestration of CD4  +   and CD8  +   T cells in 
the brains of infected HDC       /       mice.   At the coma stage (day 7 after 
infection), brains from C57BL/6 and HDC     /     mice infected with 10  6   in-
fected erythrocytes of   Pb   ANKA per mouse were taken, and leukocytes 
associated with cerebral tissue were analyzed for the presence of CD4  +  
and CD8  +   T cells and expressed as a percentage of the total cell popula-
tion and as absolute numbers per brain. Six mice per group were used. 
Values represent the means   ±   SD from three experiments.     
    Figure 7.         ICAM-1 expression in brain vessels of infected C57BL/6 
and HDC       /       mice.   (A) Histological section showing ICAM-1 expression 
indicated by immunohistochemical staining, using anti  –  ICAM-1 mAb, of 
brain sections from infected HDC     /     and C57BL/6 mice. Photographs 
from control noninfected mice (not depicted) show   <  0.5 positive vessels 
per fi  eld in both mice. (B) The number of ICAM-1  –  positive vessels per fi  eld 
in   Pb   ANKA – infected  C57BL/6  and  HDC    /     mice. No signifi  cant labeling 
could be detected in naive mice in both mouse strains (  <  0.5 positive 
vessels per fi  eld). The proportion of ICAM-1  –  positive vessels was counted 
from 10 biopsies for each sample, and three mice were used in each 
group. (C) Comparison of ICAM-1 mRNA transcripts between infected 
C57BL/6 and HDC     /     mice as measured by quantitative RT-PCR. The relative 
mRNA levels of ICAM-1 were measured using real-time RT-PCR in 
brains. The expression levels were normalized to the endogenous control 
gene GAPDH, and the relative expression levels were calculated using the 
uninfected animals as calibrators. Data are presented as the means   ±   SD 
from two independent experiments. Bar, 100    m.   JEM VOL. 205, February 18, 2008 
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between C57BL/6 and HDC      /      mice.   Of the proteins quan-
tifi  ed, the most striking diff  erences were observed in infl  am-
mation-associated proteins. Serum IL-5 levels in infected 
C57BL/6 mice were 10-fold higher than infected HDC      /      
mice (P   <   0.05). Similarly, IFN-     and keratinocyte-derived 
chemokine were, respectively, two- and threefold higher in 
infected C57BL/6 mice (P   <   0.05). Although not statistically 
signifi  cant, IL-6 and monocyte chemotactic protein 1 were 
markedly reduced in infected HDC      /      mice as compared with 
infected C57BL/6 mice. 
  Second, the expression of mRNA specifi  c for immune 
mediators was quantifi  ed. Real-time RT-PCR was used to 
evaluate cytokines of particular interest in the brains of mice 
infected for 7 d. IL-10, IFN-    , and IL-4 expressions were 
2.4, 3, and 3 times higher, respectively, in infected C57BL/6 
mice than in HDC      /      mice (  Fig. 8 B  ). In support of the serum 
protein data, IL-5 mRNA levels in the brain were consistently 
lower in HDC      /      mice (  Fig. 8  ), and treatment of C57BL/6 
mice with levocetirizine reduced cerebral IL-5 levels to those 
seen in HDC      /      mice (not depicted). Collectively, these re-
sults exemplify a divergence between C57BL/6 and HDC      /      
mice in the expression of several cytokines. Further work is 
clearly required to determine whether or not these diff  erences 
are at the basis of the resistance of HDC      /      mice to CM. 
  The antigen-induced response of specifi  c CD8  +   and CD4  + 
T cells is similarly affected by infection with   Pb   ANKA
in C57BL/6 and HDC       /       mice 
  Diff  erences in the magnitude of the CD4 and CD8 responses 
to infection between C57BL/6 and HDC      /      mice could result 
Signifi  cantly fewer ICAM-1  –  positive vessels per fi  eld (  Fig. 7 B  ) 
were observed in infected HDC      /      mice, which are refrac-
tory to CM development. Inasmuch as ICAM-1 expression 
is known to be modulated by histamine (  32, 33  ), we also de-
termined the ICAM-1 messenger RNA (mRNA) expression 
in the brains of infected mice and found that it was 2.2 times 
higher in the brains of C57BL/6 mice than in HDC      /      mice 
(P   <   0.05;   Fig. 7 C  ). Unexpectedly, VCAM-1 mRNA ex-
pression was slightly elevated in HDC      /      brain samples (see 
  Fig. 8 B  ). These results could suggest that the lower level of 
CD4  +   and CD8  +   T cells sequestered within the brain capil-
laries of infected HDC      /      mice could be at the basis of the 
failure of these mice to develop CM. Furthermore, the near 
absence of T cell sequestration in the brain of CM-resistant 
HDC      /      mice correlates with the low ICAM-1 expression 
by brain endothelial cells. 
  Differential production of immunoregulatory and effector 
molecules between C57BL/6 and HDC       /       mice infected
with   Pb   ANKA 
  The possibility exists that the resistance of HDC      /      mice to 
CM resulted from an impaired or improved capacity of these 
mice to produce some immune mediators in response to in-
fection with   Pb   ANKA. Therefore, the levels of expression of 
various relevant molecules at the mRNA and protein levels 
were compared between HDC      /      and C57BL/6 mice in-
fected with   Pb   ANKA. 
  First, serum samples at 5 d after infection with   Pb   ANKA 
were analyzed by the LINCOplex protein array (  Fig. 8 A  ) to 
evaluate diff  erences in the expression of some relevant proteins 
    Figure 8.         Differential expression of immune signaling genes in C57BL/6 and HDC       /       mice infected with   Pb   ANKA.   (A) Serum levels of specifi  c 
immune and infl  ammatory proteins were quantifi  ed at day 5 after infection by LINCOplex protein assay, and proteins with the highest variation between 
groups are displayed. (B) Transcription of cytokines and chemokines in the brain (  n     >   6 per group) 7 d after infection as evaluated by real-time RT-PCR. 
Gene mRNA expression is normalized relative to uninfected controls for each mouse strain, and control mRNA levels did not differ signifi  cantly between 
groups. Data are shown as means   ±   SD. *, P   <   0.05; #, P = 0.05.     402 HISTAMINE-MEDIATED SIGNALING IS DETRIMENTAL DURING MALARIA INFECTION | Beghdadi et al.
2.52   ±   0.01  –  fold decrease in MFI, respectively). In contrast, 
in noninfected mice from both strains, CD8 OT-1 cells and 
CD4 OT-2 cells exhibited a much higher proliferative re-
sponse (a 27.7   ±   0.06  –   and 31.5   ±   0.9  –  fold decrease in MFI 
for C57BL/6 and HDC      /      mice, respectively, for CD8  +   T 
cells; and a 12.4   ±   0.09  –   and 16.4   ±   0.07  –  fold decrease 
in MFI for C57BL/6 and HDC      /      mice, respectively, for 
CD4  +   T cells). These data indicate that the specifi  c responses 
of CD4  +   and CD8  +   T cells are equally aff  ected by infection 
with   Plasmodium   in mice from both strains and, thus, render 
unlikely the possibility that diff  erences in T cell expansion be-
tween mice from the two strains account for the observed 
dissimilarity in the susceptibility to develop CM. 
  The resistance of HDC       /       mice to CM is not affected
by depletion of CD4  +   and CD8  +   T cells 
  It is well established that CD4    +     and CD8    +     T cells contribute 
to CM pathogenesis in wild-type C57BL/6 and CBA mice, 
in view of the fact that mice depleted of CD4    +     and CD8    +     T 
cells fail to develop CM (  23  –  25  ). Furthermore, our results have 
shown that the resistance of HDC      /      mice to CM corre-
sponds to a lack of sequestration of T cells in brain capillaries 
(  Fig. 6  ). Nevertheless, we also decided to assess the possibility 
that peculiar T cell responses triggered within the distinct en-
vironment of HDC      /      mice might account for the inability 
in dissimilar manifestations of CM between mice from these 
two strains. Therefore, in an attempt to assess whether infec-
tion with   Plasmodium   interferes diff  erently with the develop-
ment of T cell responses in C57BL/6 and HDC      /      mice, the 
proliferative capacity of OVA-specifi  c CD4 and CD8 cells in 
response to specifi  c stimulation was examined in the synge-
neic environment of either infected C57BL/6 or HDC      /      
mice. 3 d after infection with   Pb   ANKA, C57BL/6 and 
HDC      /      mice were injected with either CD8 OT-1 or CD4 
OT-2 cells labeled with CFSE and treated or not with OVA. 
The proliferation of these OVA-specifi  c T cells, as refl  ected 
by a decrease in the mean fl  uorescence intensity (MFI) of 
CFSE-labeled cells, was determined by FACS analysis 3 d 
later and expressed as the ratio between the MFI of CFSE-
labeled cells recovered from mice receiving OVA to the MFI 
of similarly labeled cells recovered from mice not injected 
with OVA.   Fig. 9 A   shows a FACS quadrant analysis of rep-
resentative samples in which the numbers of CD4  +   or CD8  +   
T cells were plotted against CFSE levels.   This was quantita-
tively analyzed in   Fig. 9 B  , where no signifi  cant diff  erence in the 
proliferative response of CD8 OT-1 cells could be observed 
between infected C57BL/6 and HDC      /      mice (a 3   ±   0.09  –   
and 2.9   ±   0.1  –  fold decrease in MFI, respectively). Similarly, 
there was no diff  erence in the proliferative response of CD4 
OT-2 cells between mice from both strains (a 3.1   ±   0.2  –   and 
    Figure 9.         Similar expansion of OT-1 and OT-2 cells in infected C57BL/6 and HDC       /       mice.   Wild-type C57BL/6 and HDC     /     mice were infected 
i.p. with 10  6   infected erythrocytes of   Pb   ANKA per mouse, and 3 d later they received 5   ×   10  6   CFSE-labeled OT-1 or OT-2 cells, followed by injection or not 
of 1 mg OVA 1 h later. At day 6 after infection, spleen cells were harvested and stained either with APC  –  anti-CD8 or APC  –  anti-CD4 mAb, and quadrant 
FACS analysis was performed (A). Numbers in the top right quadrants indicate the fraction of CFSE/CD8 or CFSE/CD4 double-positive cells and the MFI, 
respectively. The proliferative response of OT-1 and OT-2 cells was expressed as a ratio between the MFI of CFSE-labeled cells from mice that received OVA 
to the MFI of those that did not (B). These data were obtained using three mice per group, and the experiment was replicated twice. Values are expressed 
as the means   ±   SD.     JEM VOL. 205, February 18, 2008 
ARTICLE
403
H1R and H2R had a signifi  cant but limited eff  ect with re-
gard to the increase in the mean survival time, possibly be-
cause the other factors or histamine receptors, H3R and H4R, 
also play a role. This is unlikely, however, because imetit 
and JNJ7777120, H3 and H4 antihistamines known to target 
H3R and H4R, neither infl  uenced parasitemia nor survival. 
Thioperamide, a nonselective H3/H4R inhibitor, was also 
tested and showed no protective eff  ect (unpublished data). 
To unequivocally determine the eff  ect of histamine on the 
course of infection with   Plasmodium  , histamine-free mice 
were used. HDC      /      mice infected with   Pb   NK65 through 
mosquito bites were highly resistant to malaria disease (90  –
  100% survival up to 35 d after infection), with only 30% of 
the mice developing blood-stage parasites, which were ulti-
mately cleared. These data strongly suggest that the absence 
of histamine either resulted in the generation of effi   cient ef-
fector responses against the preerythrocytic and blood stages 
of the parasite or limited the immunopathology associated 
with the disease. To expand these results to CM, HDC      /      
mice were infected with parasites from   Pb   ANKA. Although 
HDC      /      mice eventually succumbed from the infection with 
this strain of   Pb  , they died at much later times than similarly 
infected control C57BL/6 mice and did not exhibit any signs 
of CM. These data implicate histamine in the progression to 
CM, demonstrate that the enhanced resistance of histamine-
free mice is not restricted to parasites from a particular strain, 
and suggest that histamine signaling could lead to enhanced 
of these mice to develop CM. Such T cells could, for exam-
ple, interfere with the triggering of eff  ector T cell responses 
mediating CM pathologies in wild-type C57BL/6 mice. Thus, 
to establish whether distinct parasite-induced CD4  +   and CD8  +   
T cells interfere with the development of CM in infected 
HDC      /      mice, we studied the course of disease in mice de-
pleted of either of these subpopulations of T cells. As expected, 
depletion of both CD4  +   and CD8  +   T cells (  Fig. 10 A  ) com-
pletely abrogated the development of CM and improved the 
survival rate in C57BL/6 mice, which then died from anemia 
(median survival = 7, 21, and 37 d for mice that were untreated, 
treated with anti-CD8, or treated with anti-CD4, respectively).  
Depletion of either CD8  +   or CD4  +   T cells did not allow CM 
to manifest in HDC      /      mice (  Fig. 10 B  ). However, CD4 
T cell depletion resulted in signifi  cantly enhanced survival of 
infected HDC      /      mice (median survival = 20 and 34 d for 
untreated and anti-CD4  –  treated mice, respectively;   Fig. 10 B  ). 
These data do not clearly support a role for CD8 and CD4 
T cells in the resistance of HDC      /      mice to CM, but they draw 
attention to a possible involvement of CD4  +   T cells in malaria 
pathologies other than CM in HDC      /      and C57BL/6 mice. 
    DISCUSSION   
  Histamine is recognized as a key factor in the pathogenesis of 
allergic diseases. Levocetirizine, a selective H1 antihistamine, 
controls seasonal allergic rhinitis symptoms in children (  34  ). 
Use of sedating H1R blockers was also associated with a de-
creased risk of developing multiple sclerosis (  35  ) and improved 
the quality of life of patients with chronic idiopathic urticaria 
(  36  ), suggesting a possible benefi  cial eff  ect of antihistamines 
on the onset of some autoimmune diseases. Increased histamine 
in plasma and tissues is associated with disease severity in 
human infections with   P. falciparum   and in animal models of 
malaria (  6  –  8, 22  ). 
  Apart from the correlation with immunopathogenesis in 
other diseases, little is known of the role of histamine in malaria. 
In this study, we analyzed the infl  uence of histamine on the 
course of disease in mice infected with   Pb   from two diff  erent 
strains that induce distinct pathologies. This work evaluated the 
hypothesis that the histamine signaling during infection with 
  Plasmodium   results in an infl  ammatory process that exacerbates 
disease by inducing immunopathology or facilitating the dis-
semination, adherence, and sequestration of parasites in tissues. 
Based on divergent approaches using H1R      /      and H2R      /      
mice, antihistamine drugs, and histamine-defi  cient mice, 
we demonstrate that histamine signaling is associated with 
the severity of disease. 
  The mechanisms by which histamine contributes to dis-
ease severity and at which stage of the parasite life cycle they 
operate is unclear. Mice genetically defi  cient in H1R and 
H2R, as well as mice treated with H1 and H2 antihistamines, 
have delayed mortality as compared with similarly infected 
wild-type mice untreated with the antihistamines, suggesting 
that the production and binding of histamine to these two re-
ceptors are deleterious to the host. However, antagonizing 
the eff  ects of histamine by interference only at the levels of 
    Figure 10.         In vivo depletion of CD4 or CD8 T cells did not alter 
resistance of HDC       /       mice to lethal infection by   Pb   ANKA.   Wild-type 
C57BL/6 (A and C) and HDC     /     (B and D) mice were left untreated 
(squares) or treated with neutralizing anti-CD4 (triangles) or anti-CD8 
mAb (diamonds) before and during infection with 10  6    Pb   ANKA – infected 
erythrocytes per mouse. Survival rates (A and B) and parasitemia (C and D) 
were recorded over time. Six mice per group were used, and data 
are shown as means   ±   SD. This experiment was replicated twice. 
Significant differences in A were observed between untreated and 
anti-CD8  –  treated (*, P   <   0.001) and anti-CD4  –  treated (**, P   <   0.0001) 
mice. A signifi  cant difference in B was observed only with anti-CD4  –  treated 
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stop the adverse eff  ects of hyperparasitemia. In addition to its 
distinctive effi   ciency in producing CM in mice, the possi-
bility exists that   Pb   ANKA also elicits infl  ammatory media-
tors, other than histamine, that promote the progression of 
infection even in HDC      /      mice. Indeed, analysis of several 
infl  ammatory proteins and other immune response  –  associ-
ated molecules, including IFN-    , IL-6, IL-10, keratinocyte-
derived chemokine (KC), monocyte chemotactic protein 1 
(MCP-1), macrophage infl  ammatory protein 1     (MIP-1    ), 
cytotoxic T lymphocyte  –  associated protein 4, and inducible 
co-stimulator (  Fig. 8  ; and not depicted), indicates that an 
infl  ammatory response, although attenuated, was induced in 
HDC      /      mice. Several studies indicate that the CM patholo-
gies seen in mice after infection with   Pb   ANKA result from 
the induced proinfl  ammatory immune response. In agreement, 
IFN-    , which was shown to be implicated in the pathogene-
sis of experimental CM (  38  ), reached signifi  cantly higher lev-
els in the brain tissue and plasma of CM-sensitive C57BL/6 
mice than in HDC      /      mice (  Fig. 8, A and B  ). Similarly, our 
results showing higher levels of IL-6 in the plasma and in-
creased expression of IL-6 transcripts in the brain of CM-
sensitive C57BL/6 than in HDC      /      mice are also in agreement 
with studies showing higher production of IL-6 in response 
to TNF-     by endothelial cells of brain capillaries of mice ge-
netically sensitive to CM development (  39  ). Our results, which 
diverge from murine CM experiments that suggest a protec-
tive eff  ect for IL-10 in CM (  40  ) but are in accordance with 
observations in humans that showed an increase in IL-10 
with CM as compared with mild malaria patients (  41  ), show 
a lower cerebral expression of IL-10 by HDC      /      mice. IL-4 
expression corresponds with CM in our model, in agreement 
with previous studies that demonstrate that defi  ciency in IL-4 
or IL-4R     leads to higher resistance to   Pb   ANKA (  42  ). 
  Analogous to the present data that reveal the adverse ef-
fects of histamine for the host during infection with   Plasmo-
dium  , a human study demonstrated that the concentration of 
histamine in plasma was increased by almost fi  vefold in chil-
dren suff  ering from malaria (  22  ). Additionally, in this study, 
higher levels of histamine were observed in the brains of chil-
dren with severe malaria as compared to lesser disease presen-
tations. Among the histamine-associated biological activities 
relevant to features predictive of severe CM in humans are 
increased intracerebral blood fl  ow (  43  ), increased vascular 
and BBB permeability (  44  ), and edema (  45  ). Strikingly, the 
resistance of histamine-defi  cient mice to CM was clearly 
identifi  ed by a preserved BBB integrity, in contrast to the greatly 
increased permeability of the brain vasculature with large clusters 
of infected erythrocytes observed in infected C57BL/6 mice. 
  In the absence of histamine signaling, profound altera-
tions of the immune response may also occur. A characteris-
tic feature of CM is the sequestration of CD8  +   and CD4  +   T 
cells in the brain capillaries (  46  –  48  ). This was confi  rmed by 
results in this study showing a 3.7- and 2.7-fold increase of 
CD8  +   and CD4  +   T cells, respectively, in the brain of C57BL/6 
mice infected with   Pb   ANKA. Such sequestration in the brain 
was not observed in similarly infected HDC      /      mice (  Fig. 6  ). 
immunopathological responses. Importantly, results showing 
comparable parasitemia between groups infected with para-
sites from   Pb   ANKA do not support the possibility that the 
inability of histamine-free mice to develop CM resulted from 
a reduced parasite burden. 
  In an attempt to better determine at which stage of parasite 
development histamine mediates its adverse eff  ects, HDC      /      
mice were also infected with   Pb   ANKA    –    parasitized RBCs, 
thus bypassing the preerythrocytic phase. Identical to what 
was observed after infectious mosquito bites, histamine-free 
mice did not develop CM and survived signifi  cantly longer 
than similarly infected control C57BL/6 mice. These data 
indicate that although histamine is produced during all stages 
of infection with   Plasmodium   parasites (i.e., by histamine-pro-
ducing MCs in the skin and in the liver during the preerythro-
cytic stage of parasites development, and by histamine-producing 
basophils in the blood where infected RBCs circulate), the 
pathogenic eff  ects of histamine are likely prevailing in the 
latter stages of infection. However, the possibility that hista-
mine also plays a role in the skin and/or the liver during the 
initial phases of the infection cannot be excluded. Indeed, 
during the initial phases of the infection, specifi  cally the pre-
erythrocytic stages of parasite development, histamine release 
may be triggered in the dermis when sporozoites are inocu-
lated via mosquito bites. In this context,   Anopheles   saliva in-
duces MC degranulation (  1  ). During later phases of infection, 
particularly during the blood stage of parasite development, 
histamine production can be elicited from circulating baso-
phils either via the cross-linking of parasite-specifi  c IgE anti-
bodies or by TCTP, a parasite-derived homologue of the 
histamine-releasing factor. TCTP has been found in the 
plasma of patients infected with   P. falciparum   and was shown 
to trigger histamine release from basophils and IL-8 secretion 
from eosinophils (  37  ). The existence of a   Plasmodium   protein 
that stimulates histamine release lends support to the hypoth-
esis that histamine signaling is advantageous to the pathogen 
and, thus, harmful to the host. These fi  ndings could provide 
a rational basis for higher levels of histamine in blood and in 
tissues during malaria as a result of the activity of vector- or 
parasite-derived constituents. Our results (  Fig. 1  ) clearly revealed 
a progressive increase in histaminemia during the course of in-
fection in C57BL/6 mice. Amplifying the host infl  ammatory 
response via histamine signaling may be a strategy developed 
by the parasites to create conditions advantageous for their 
own survival and persistence. Although the parasites from the 
two strains used in our study are lethal for mice, the disease 
courses that they elicit are quite diff  erent. Our results in 
HDC      /      mice show that in the absence of histamine, the 
disease severity induced by both parasites was signifi  cantly 
attenuated. The adverse eff  ect of histamine is highlighted 
by the survival induced after infection with   Pb   NK65 and a 
delayed non-CM death from   Pb   ANKA resulting from the 
interruption of histamine signaling. The reason that infection 
with   Pb   ANKA remains lethal in histamine-free HDC      /      
mice is unclear. It seems plausible that even though inhibiting 
histamine signaling may abrogate immunopathology, it cannot JEM VOL. 205, February 18, 2008 
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of the   Pb  -specifi  c T cell response is currently being compared 
between C57BL/6 and HDC      /      mice. Our results are con-
sistent with previous fi  ndings showing that during an acute 
blood-stage malaria infection T cell responses to   Plasmodium   
parasites and other bystander antigens are inhibited (  53  ). Thus, 
the mechanism by which HDC      /      mice resist CM does not 
appear to stem from a   Pb   ANKA  –  induced modifi  cation of 
the peripheral T cell responses, though one could argue that 
the absence of HDC expression may alter histamine-mediated 
infl  ammatory responses that are necessary for the manifesta-
tion of some eff  ector functions exerted by CD4  +   and CD8  +   
T cell responses. 
  To demonstrate directly and unequivocally the implica-
tion of histamine in the pathogenesis of CM, attempts were 
made to revert the CM-resistant phenotype (HDC      /     ) by 
frequent injections of histamine into   Pb   ANKA  –  infected mice. 
Such treatment failed to induce signifi  cant alterations in mor-
tality (unpublished data). This method of repleting mice may, 
however, not be suffi   cient because of the low bioavailability 
and the lability of histamine (  54  ). Nevertheless, our results 
with antihistamines and genetic knockouts strongly suggest 
that antihistamine could have a therapeutic value in the treat-
ment of malaria infection, particularly by reducing the likeli-
hood of adverse complications. This is supported by the fact 
that antihistaminic drugs such as chlorpheniramine potentiate 
the anti-  Plasmodium   eff  ect of mefl  oquine, quinine, or pyronar-
idine (  55  ). It should be pointed out that the antihistamine 
drugs do not very likely exert their eff  ect directly on the par-
asite. We performed an experiment in which infected eryth-
rocytes treated with the H1R blocker levocetirizine were 
compared with untreated infected erythrocytes for their ca-
pacity to infect mice. No signifi  cant diff  erence regarding sur-
vival or parasitemia was observed between the two groups of 
mice, suggesting that H1 antihistamine drugs exert no direct 
eff  ect on the parasite (unpublished data). 
  The present work represents the fi  rst  comprehensive 
study documenting the role of histamine in the development 
of severe pathologies during infection with   Plasmodium  . Al-
though malaria vaccine development remains a central and 
ultimate goal, alternative chemotherapy-based approaches such 
as histamine receptor antagonists have the potential to be 
highly valuable. Such treatment could be part of an integrated 
control strategy and could also be a useful candidate in inter-
mittent preventive treatment strategies that target specifi  c 
high-risk groups, such as children and pregnant women. Fur-
thermore, given the availability of antihistamines, such treat-
ment could be implemented rapidly to alleviate the burden of 
malaria in endemic areas. 
  MATERIALS AND METHODS 
  Animals.     6  –  8-wk-old female C57BL/6 mice were purchased from Charles 
River Laboratories. HDC      /      (  56  ) and H1R and H2R knockout (H1R      /      
and H2R      /     ) (  57, 58  ) mice were provided by H. Ohtsu and T. Watanabe, 
respectively. All knockout mice originated from the C57BL/6 background. 
  The mice, including OT-1 and OT-2 transgenic mice (  59  ), were bred 
in our animal facility. OT-1 mice are transgenic for a TCR that recognizes 
the OVA peptide 257  –  264 in the context of H2K  b  . OT-2 mice express a 
These data suggest that the histamine produced after infection 
with   Pb   ANKA triggers infl  ammation that leads to the seques-
tration of T cells in brain capillaries, a prominent component 
of CM pathogenesis. In this context, it has been reported that 
histamine is essential for the recruitment of antigen-specifi  c 
CD4  +   and CD8  +   T cells into the site of antigen delivery and 
the subsequent generation of infl  ammatory responses (  12  ). 
  Several studies reported a crucial role of ICAM-1 in ma-
laria pathogenesis, and notably, ICAM-1  –  defi  cient mice are 
protected from CM (  49  ). In this model, ICAM-1      /      mice 
survived   >  15 d despite a similar level of parasitemia in wild-
type and knockout mice, a phenotype that is comparable to 
HDC      /      mice. Results from our study confi  rmed the corre-
lation between ICAM-1 expression, both at the protein and 
transcript levels, and susceptibility to CM. The low levels of 
ICAM-1 expression in brain microvascular endothelial cells 
in histamine-defi  cient HDC      /      mice (  Fig. 8  ) could represent 
a mechanism leading to the lack of T cell sequestration in the 
brain capillaries of these mice. It is interesting to note that 
ICAM-1      /      and HDC      /      mice, which express similar phe-
notypes, have in common a reduced synthesis of ICAM-1 
molecules, suggesting a control mechanism exerted by hista-
mine on ICAM-1 expression. Indeed, histamine has been 
shown to stimulate endothelial cells to express ICAM-1 and 
VCAM-1 (  32  ), and cetirizine, a H1R antagonist, has recently 
been shown to have antiinfl  ammatory properties through the 
inhibition of leukocyte recruitment and activation, and by 
the reduction of ICAM-1 expression on keratinocytes (  50  ) 
and on conjunctival and nasal epithelial cells (  33  ). Interest-
ingly, a reduction in ICAM-1 and VCAM-1 expression was 
observed in the brain tissue of infected C57BL/6 mice treated 
with levocetirizine (unpublished data). In one study, VCAM-1 
was identifi  ed by microarray analysis as a candidate gene that 
discriminates between CM-resistant and -sensitive mice in a 
  Pb   model of CM (  51  ). Our data do not support the assertion 
that elevated VCAM-1 corresponds to CM, as we observed 
slightly higher VCAM-1 mRNA levels in HDC      /      mice 
(P   <   0.05) as compared with C57BL/6 mice, suggesting an 
uncertain or, perhaps, protective role for this adhesion mole-
cule in our model. In accordance with our observation of a 
predominant role for ICAM-1 as compared with VCAM-1 in 
malaria pathogenesis, infusion of anti  –  ICAM-1 but not anti  –
  VCAM-1 mAb prevents cytoadherence of infected erythro-
cytes in a   P. yoelii   model of CM (  52  ). 
  A possible dissimilarity in the magnitude and quality of 
the CD4 and CD8 responses elicited by infection with   Pb   
ANKA in C56BL/6 and HDC      /      mice could account for 
the lack of CM in HDC      /      mice. Such diff  erences in the 
magnitude of the T cell responses could be the result of a di-
vergent ability to suppress antigen-specifi  c T cell responses in 
C57BL/6 and HDC      /      mice. 
  Our results showing a similar eff  ect of infection with   Plas-
modium   on the specifi  c proliferative response of OT-1 and 
OT-2 cells in C57BL/6 and HDC      /      mice suggest that the 
magnitude of T cell responses is similarly aff  ected in C57BL/6 
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then injected with 10  6   pRBCs infected with   Pb   ANKA, and 200   μ  g of antibodies 
was administered every other day until completion of the experiment. 
  Flow cytometric analysis of brain and spleen leukocytes.     Spleen and 
brain cells were stained for FACS analysis according to standard protocols in 
cold PBS containing 2% FCS and 0.01% sodium azide (FACS buff  er) with 
the following antibodies: APC-labeled CD4, APC-labeled anti-CD8    , 
and PE-labeled antiperforin. RBCs were eliminated using cell lysis buff  er, 
and cells were washed in FACS buff  er. After staining with anti-CD4 or anti-
CD8     antibodies, cells were washed and resuspended in fi  xation/permeabi-
lization solution for 20 min at 4 °  C. Fixed/permeabilized cells were resuspended 
in Perm/Wash buff  er (BD Biosciences) for before fl  ow cytometric analysis. 
A total of 4   ×   10  4   and 10  5   living cells for brain and spleen, respectively, were 
analyzed using a four-color fl  ow cytometer (FACSCalibur) with CellQuest 
Pro software (both from BD Biosciences). 
  Permeability of the BBB.     When mice infected with   Pb   ANKA began show-
ing neurological symptoms, usually at day 6  –  7 after infection, a 200-  μ  l volume of 
a 2% (wt/vol) solution of Evans blue in PBS was injected into the mice retro-
orbitally. 1 h later, mice were perfused with PBS after anesthesia with 600 mg/kg 
ketamine and 20 mg/kg xylazine. Each brain was removed and photographed. 
  Animal perfusion and histological analysis.     For the May-Gr  ü  nwald 
Giemsa (MGG) staining procedure and immunohistochemical studies, the 
protocols used to obtain 5-    m-thick brain sections were described previ-
ously (  62  ). Detection of blood-stage parasites associated with sequestered 
erythrocytes in the brain could be visualized either by MGG staining or by 
fl  uorescence because of their expression of GFP. Images of randomly se-
lected endplates were collected using an upright microscope (BX61; Olympus) 
equipped with an oil immersion lens (60  ×  ) and a cooled video camera 
(Retiga 2000R; QImaging) with a color conversion fi  lter. Digitizing was 
performed with a computer using the image analysis system Image-Pro Plus 
(Media Cybernetics). Detection of VCAM-1 and ICAM-1 was performed 
by using specifi  c mAbs (clones 429 and 3E2, respectively), followed by bio-
tin-conjugated goat anti  –  rat IgG-specifi  c polyclonal antibody (for VCAM-1) 
and mouse anti  –  hamster antibody (for ICAM-1). Streptavidin peroxidase 
and 3-amino-9-ethylcarbazole, as substrates, were added thereafter. All anti-
bodies were obtained from BD Biosciences. 
  Cytokine and chemokine quantifi  cation in the brain and serum.     To 
evaluate shifts of immune mediators in serum, LINCOplex protein arrays were 
performed on day 5 serum samples from HDC      /      and C57BL/6 mice, accord-
ing to the standard protocol. Cytokine and chemokine expression in the brain 
at day 7 was analyzed by real-time RT-PCR. RNA used for these assays was 
isolated by means of a two-step extraction process. First, brains were surgically 
removed from mice, in Preparation of brain cell suspensions, and placed imme-
diately in RNAlater (Ambion) at 4  °  C overnight. After RNAlater infused the 
samples, it was removed and samples were maintained at     80  °  C until processing. 
Brains were thawed in 1 ml of TRI  zol   and subjected to bead disruption in a 
polytron three times for 2 min at a setting of 30 cycles per second. Samples were 
spun at high speed (10,000   g  ) for 3 min to remove debris and lipids. Half of 
the sample was transferred to a new tube and mixed with 500   μ  l of TRI  zol   
reagent by vortexing. After this step, RNA extraction proceeded according 
to the manufacturer  ’  s protocol. Precipitated RNA was resuspended in 100   μ  l 
of RNase-free water. The second step of this extraction was in accordance with 
the manufacturer  ’  s protocol for RNA cleanup, including steps for the removal 
of protein and DNA (RNeasy kit; QIAGEN). Samples were eluted with 50   μ  l 
of RNase-free water, and quality and quantity were assured by photospectros-
copy. Real-time RT-PCR used various primer-probe sets and standard 
Taqman protocols (Applied Biosystems), as previously described (  63  ). 
  Statistical analysis.     Statistical signifi  cance was assessed by the Student  ’  s 
  t   test, except for survival. Signifi  cant diff  erences in survival were evaluated 
by the generation of Kaplan-Meier plots and log-rank analysis. P   <   0.05 was 
considered statistically signifi  cant. 
transgenic TCR, which recognizes the OVA peptide 323  –  339 in the con-
text of I-A  b  . All animal care and experimentation were conducted in accor-
dance with the Pasteur Institute animal care and use committee guidelines. 
    An. stephensi   (SDA 500 strain) mosquitoes were raised at the Center of 
Production and Infection of Anopheles (CEPIA) of the Institut Pasteur using 
standard procedures, as previously described (  1  ). 
  Parasites and infection.     For all infections,   Pb   NK65 or   Pb   ANKA lines ex-
pressing GFP on circumsporozoite (  60  ) or the hsp70 promoter (  61  ), respec-
tively, were used to allow the detection of sporozoites in living mosquitoes. 
  Pb   ANKA was provided by T. Ishino (Mie University School of Medicine, 
Edobashi, Tsu, Japan). This parasite induces experimental CM, characterized 
by paralysis, ataxia, convulsions, and coma between 7  –  9 d after infection.   Pb   
NK65 induces lethal malaria without neurological symptoms and was pro-
vided by R. M  é  nard (Institut Pasteur, Paris, France). These parasites were 
maintained in a cycle between C57BL/6 mice and   An. stephensi  . The eryth-
rocytic stages of the parasite were maintained in liquid nitrogen as parasitized 
RBCs (pRBCs) in Alsever  ’  s solution (Sigma-Aldrich) containing 10% glycerol. 
The infection was induced by i.p. injection of 10  6   pRBCs or by exposure of 
mice to mosquito bites (seven to nine bites per mouse). 
  Treatment with antihistamine drugs.     The histamine receptor subclass-
specifi  c inhibitors cimetidine, imetit, and JNJ 7777120 (H2R, H3R, and 
H4R, respectively; Sigma-Aldrich) were injected i.p. daily at 10 mg/kg for 
10 d, starting 24 h before infection. Levocetirizine (H1R), obtained from 
UCB, was used at 10 mg/kg. Histamineamia was determined using ELISA 
kits purchased from Neogen Corporation. 
  Preparation of brain cell suspensions.     The brains were obtained from 
wild-type  –  susceptible C57BL/6 mice at the coma stage of CM and at the 
same time from HDC      /      mice (day 6). In brief, mice anesthetized with 
600 mg/kg ketamine and 20 mg/kg xylazine were perfused with 150 ml PBS. 
Each brain was then removed and homogenized in RPMI 1640 medium 
(BioWhittaker) by passing through sterile meshes to obtain a single-cell sus-
pension. Percoll (GE Healthcare) was added at a fi  nal concentration of 35% to 
the cell pellet and centrifuged at 400   g   for 20 min at 20  °  C. The cell pellet was 
washed twice and analyzed via fl  ow cytometry. 
  In vivo study of CFSE-labeled T cell proliferation.     Splenocytes were 
prepared from OT-1 and OT-2 mice. Cell suspensions were prepared by 
passing through sterile meshes. Erythrocytes were lysed using RBC lysis buf-
fer (Sigma-Aldrich). Cells were washed twice in RPMI 1640 medium, and 
live cells were counted using Trypan blue exclusion staining and adjusted to 
10  7   cells per milliliter. CD8  +   OT-1 or CD4  +   OT-2 cells were purifi  ed with 
MACS beads according to the manufacturer  ’  s instructions (Miltenyi Biotec), 
and cells were stained with allophycocyanin (APC)-conjugated anti-CD8 or 
APC-conjugated anti-CD4 antibodies, and the purity was     95% as evalu-
ated by FACS analysis. Staining of spleen cells with CFSE (Invitrogen) was 
performed according to the manufacturer  ’  s instructions. Recipient mice 
(C57BL/6, HDC      /     ) were inoculated 3 d after infection with 10  6   pRBCs 
i.v. with either 5   ×   10  6   purifi  ed CFSE-CD8  +   OT-1 or CFSE-CD4  +   OT-2 
cells. Mice were injected 1 h later with 1 mg OVA. Single-cell suspensions 
of spleens of the recipients were analyzed 3 d after adoptive cell transfer. 
  In vivo depletions.     Rat IgG2a anti-CD4 mAb (clone GK1.5; American 
Type Culture Collection) and rat IgG2b anti-CD8 mAb (clone 2.43; American 
Type Culture Collection) were provided by L. R  é  nia (Institut Cochin, Paris, 
France). Purifi  ed control rat antibodies were purchased from Sigma-Aldrich. 
Antibodies were purifi  ed from culture supernatants by ammonium sulfate pre-
cipitation. Mice were injected i.p. with 500   μ  g anti-CD8 mAb, anti-CD4 mAb, 
or control rat IgG on days 1 and 0 before challenge. More than 98% of blood 
CD8  +   or CD4  +   T cells were depleted by this procedure, as verifi  ed by cyto-
fl  uorometry (FACScan; BD Biosciences) using anti-CD4 (clone H129-19; 
Sigma-Aldrich) and anti-CD8 (clone 53-6.7; BD Biosciences) mAbs that rec-
ognized epitopes diff  erent from those bound by the depleting mAbs. Mice were JEM VOL. 205, February 18, 2008 
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